The DOI matches its Crossref record; 304 of the 304 references it cites were found in a registry or an index.
Recent progress in targeted delivery vectors based on biomimetic nanoparticles
Open accessAbstract
Over the past decades, great interest has been given to biomimetic nanoparticles (BNPs) since the rise of targeted drug delivery systems and biomimetic nanotechnology. Biological vectors including cell membranes, extracellular vesicles (EVs), and viruses are considered promising candidates for targeted delivery owing to their biocompatibility and biodegradability. BNPs, the integration of biological vectors and functional agents, are anticipated to load cargos or camouflage synthetic nanoparticles to achieve targeted delivery. Despite their excellent intrinsic properties, natural vectors are deliberately modified to endow multiple functions such as good permeability, improved loading capability, and high specificity. Through structural modification and transformation of the vectors, they are pervasively utilized as more effective vehicles that can deliver contrast agents, chemotherapy drugs, nucleic acids, and genes to target sites for refractory disease therapy. This review summarizes recent advances in targeted delivery vectors based on cell membranes, EVs, and viruses, highlighting the potential applications of BNPs in the fields of biomedical imaging and therapy industry, as well as discussing the possibility of clinical translation and exploitation trend of these BNPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–304 of 304
Engineered Phagemids for Nonlytic, Targeted Antibacterial Therapies
Krom, R. J., Bhargava, P., Lobritz, M. A., & Collins, J. J. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b01943 · Cited by 114
Rao, L., He, Z., Meng, Q., Zhou, Z., Bu, L., Guo, S., Liu, W., & Zhao, X. (2016) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35927 · Cited by 114
Self-citationLiu, J., Zhang, D., Fang, G., & Wang, S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.042 · Cited by 114
Zhang, X., He, S., Ding, B., Qu, C., Zhang, Q., Chen, H., Sun, Y., Fang, H., Long, Y., Zhang, R., et al. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.123959 · Cited by 114
Steinmetz, N. F., Ablack, A. L., Hickey, J. L., Ablack, J., Manocha, B., Mymryk, J. S., Luyt, L. G., & Lewis, J. D. (2011) · Small · doi:10.1002/smll.201000435 · Cited by 112
Sun, X., Li, W., Zhang, X., Qi, M., Zhang, Z., Zhang, X., & Cui, Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b02386 · Cited by 112
Hu, H., Zhang, Y., Shukla, S., Gu, Y., Yu, X., & Steinmetz, N. F. (2017) · ACS Nano · doi:10.1021/acsnano.7b04472 · Cited by 110
Extracellular vesicles in the diagnosis and treatment of central nervous system diseases
Rizvanov, A. A., Shaimardanova, A. A., Solovyeva, V. V., Chulpanova, D. S., James, V. H., & Kitaeva, K. V. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.266908 · Cited by 110
Zhao, H., Zhao, B., Li, L., Ding, K., Xiao, H., Zheng, C., Sun, L., Zhang, Z., & Wang, L. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201901335 · Cited by 110
Messenger RNA vaccine based on recombinant MS2 virus‐like particles against prostate cancer
Li, J., Sun, Y., Jia, T., Zhang, R., Zhang, K., & Wang, L. (2013) · International Journal of Cancer · doi:10.1002/ijc.28482 · Cited by 109
Xie, J., Shen, Q., Huang, K., Zheng, T.-Y., Cheng, L., Zhang, Z., Yu, Y., Liao, G., Wang, X., & Li, C. (2019) · ACS Nano · doi:10.1021/acsnano.8b09681 · Cited by 109
Li, R., Xiaohua, T., Li, Y., Zhang, H., Ma, R., Ji, T., Dong, W., Tong, T., Liu, Y., Chen, D., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.025 · Cited by 105
Virus-like nanoparticles as a novel delivery tool in gene therapy
Jeevanandam, J., Pal, K., & Danquah, M. K. (2018) · Biochimie · doi:10.1016/j.biochi.2018.11.001 · Cited by 105
Biomimetic Natural Killer Membrane Camouflaged Polymeric Nanoparticle for Targeted Bioimaging
Pitchaimani, A., Nguyen, T. D. T., Marasini, R., Eliyapura, A., Azizi, T., Jaberi‐Douraki, M., & Aryal, S. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201806817 · Cited by 100
Lu, B., Javidi-Parsijani, P., Makani, V. S., Mehraein‐Ghomi, F., Sarhan, W. M., Sun, D., Yoo, K. W., Atala, Z., Lyu, P., & Atala, A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz093 · Cited by 99
Safety Considerations of Cancer Nanomedicine—A Key Step toward Translation
Liu, X., Tang, I., Wainberg, Z. A., & Meng, H. (2020) · Small · doi:10.1002/smll.202000673 · Cited by 99
Cell Targeting with Hybrid Qβ Virus‐Like Particles Displaying Epidermal Growth Factor
Pokorski, J. K., Hovlid, M. L., & Finn, M. G. (2011) · ChemBioChem · doi:10.1002/cbic.201100469 · Cited by 97
Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents
Bruckman, M. A., Hern, S., Jiang, K., Flask, C. A., Yu, X. G., & Steinmetz, N. F. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb00461a · Cited by 97
Extracellular vesicles in cancer nanomedicine
Tarasov, V. V., Svistunov, A. A., Chubarev, V. N., Dostdar, S. A., Sokolov, A. V., Brzecka, A., Sukocheva, O., Neganova, M. E., Klochkov, S. G., Somasundaram, S. G., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.017 · Cited by 97
Wang, Y., Luan, Z., Zhao, C., Bai, C., & Yang, K. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105136 · Cited by 97
Glycan-Targeted Virus-like Nanoparticles for Photodynamic Therapy
Rhee, J., Baksh, M. M., Nycholat, C. M., Paulson, J. C., Kitagishi, H., & Finn, M. G. (2012) · Biomacromolecules · doi:10.1021/bm300578p · Cited by 96
Role of the interaction between galectin-3 and cell adhesion molecules in cancer metastasis
Xin, M., Dong, X.-W., & Guo, X. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.11.024 · Cited by 95
Bruckman, M. A., Czapar, A. E., VanMeter, A., Randolph, L. N., & Steinmetz, N. F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.045 · Cited by 95
Zhu, J., Sevencan, C., Zhang, M., McCoy, R. S. A., Ding, X., Ye, J., Xie, J., Ariga, K., Feng, J. X., Bay, B., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b08798 · Cited by 95
Walker, A., Skamel, C., & Nassal, M. (2011) · Scientific Reports · doi:10.1038/srep00005 · Cited by 94
Xie, X., Hu, X., Li, Q., Yin, M., Song, H., Hu, J., Wang, L., Fan, C., & Chen, N. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c01503 · Cited by 94
Prel, A., Caval, V., Gayon, R., Ravassard, P., Duthoit, C. T., Payen, E., Maouche-Chretien, L., Crénéguy, A., Nguyen, T. H., Martin, N., et al. (2015) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2015.39 · Cited by 93
Chemical modification of the adeno-associated virus capsid to improve gene delivery
Mével, M., Bouzelha, M., Leray, A., Pacouret, S., Guilbaud, M., Penaud-Budloo, M., Alvarez-Dorta, D., Dubreil, L., Gouin, S. G., Combal, J. P., et al. (2020) · Chemical Science · doi:10.1039/c9sc04189c · Cited by 92
Programmed Self-Assembly of an Active P22-Cas9 Nanocarrier System
Qazi, S., Miettinen, H. M., Wilkinson, R. A., McCoy, K., Douglas, T., & Wiedenheft, B. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00822 · Cited by 92
Targeted anti–IL-1β platelet microparticles for cardiac detoxing and repair
Li, Z.-H., Hu, S.-Q., Huang, K., Su, T., Cores, J., & Cheng, K. (2020) · Science Advances · doi:10.1126/sciadv.aay0589 · Cited by 92
Virus like particles as a platform for cancer vaccine development
Ong, H. K., Tan, W. S., & Ho, K. L. (2017) · PeerJ · doi:10.7717/peerj.4053 · Cited by 87
Wang, K., Lei, Y., Xia, D., Xu, P., Zhu, T., 江, 鐘., & Ma, Y. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110755 · Cited by 86
Crosby, E. J., Gwin, W. R., Blackwell, K., Marcom, P. K., Chang, S., Maecker, H. T., Broadwater, G., Hyslop, T., Kim, S., Rogatko, A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3102 · Cited by 85
Pearson, R. M., Podojil, J. R., Shea, L. D., King, N. J. C., Miller, S. D., & Getts, D. R. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.10.001 · Cited by 83
Delivery of siRNA therapeutics using cowpea chlorotic mottle virus-like particles
Lam, P., & Steinmetz, N. F. (2019) · Biomaterials Science · doi:10.1039/c9bm00785g · Cited by 82
Small-Molecule Lanthanide Complexes Probe for Second Near-Infrared Window Bioimaging
Yang, Y., Wang, P., Lu, L., Fan, Y., Sun, C., Fan, L., Xu, C., El‐Toni, A. M., Alhoshan, M. S., & Zhang, F. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b00603 · Cited by 81
Franke, C. E., Czapar, A. E., Patel, R. B., & Steinmetz, N. F. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00466 · Cited by 78
Modular Hepatitis B Virus-like Particle Platform for Biosensing and Drug Delivery
Hartzell, E. J., Lieser, R. M., Sullivan, M. O., & Chen, W. (2020) · ACS Nano · doi:10.1021/acsnano.9b08756 · Cited by 77
Advances in the application of upconversion nanoparticles for detecting and treating cancers
Li, K., Hong, E., Wang, B., Wang, Z., Zhang, L., Hu, R., & Wang, B. (2018) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2018.12.007 · Cited by 76
Development of a virus-mimicking nanocarrier for drug delivery systems: The bio-nanocapsule
Somiya, M., & Kuroda, S. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.003 · Cited by 70
Schwarz, B. H., Madden, P. J., Avera, J., Gordon, B., Larson, K., Miettinen, H. M., Uchida, M., LaFrance, B. J., Basu, G., Rynda‐Apple, A., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b03360 · Cited by 70
Tian, Y., Zhou, M., Shi, H., Gao, S., Xie, G., Zhu, M., Wu, M., Chen, J., & Niu, Z. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01805 · Cited by 70
Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector
Ni, L., Scott, L., Campbell, H. M., Pan, X., Alsina, K. M., Reynolds, J. O., Philippen, L. E., Hulsurkar, M. M., Lagor, W. R., Li, N., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.313811 · Cited by 70
Yukawa, H., Suzuki, K., Aoki, K., Arimoto, T., Yasui, T., Kaji, N., Ishikawa, T., Ochiya, T., & Baba, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-24563-0 · Cited by 69
Production and biomedical applications of virus-like particles derived from polyomaviruses
Teunissen, E. A., de Raad, M., & Mastrobattista, E. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.026 · Cited by 68
Development of target‐tunable P22 VLP‐based delivery nanoplatforms using bacterial superglue
Kim, H., Choi, H., Bae, Y., & Kang, S. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27129 · Cited by 67
Xu, P., Tang, K., Ma, J., Zhang, H., Wang, D., Zhu, L., Chen, J., Wei, K., Liu, J., Fang, H., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0789 · Cited by 67
Toxoid Vaccination against Bacterial Infection Using Cell Membrane-Coated Nanoparticles
Angsantikul, P., Fang, R. H., & Zhang, L. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00692 · Cited by 65
Shan, W., Zhang, D., Wu, Y., Lv, X., Hu, B., Zhou, X., Ye, S., Bi, S., Ren, L., & Zhang, X. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.12.002 · Cited by 62
Development of viral nanoparticles for efficient intracellular delivery
Wu, Z., Chen, K., Yıldız, İ., Dirksen, A., Fischer, R., Dawson, P. E., & Steinmetz, N. F. (2012) · Nanoscale · doi:10.1039/c2nr30366c · Cited by 61
Biodistribution of Antibody-MS2 Viral Capsid Conjugates in Breast Cancer Models
Aanei, I. L., ElSohly, A. M., Farkas, M. E., Netirojjanakul, C., Regan, M., Murphy, S. T., O’Neil, J. P., Seo, Y., & Francis, M. B. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00566 · Cited by 61
Guo, L., Zhang, Y., Wei, R., Zhang, X., Wang, C., & Feng, M. (2020) · Theranostics · doi:10.7150/thno.45528 · Cited by 61
Engineering the PP7 Virus Capsid as a Peptide Display Platform
Zhao, L., Kopylov, M., Potter, C. S., Carragher, B. O., & Finn, M. G. (2019) · ACS Nano · doi:10.1021/acsnano.8b09683 · Cited by 60
Synthetic virology: engineering viruses for gene delivery
Guenther, C. M., Kuypers, B. E., Lam, M. T., Robinson, T. M., Zhao, J. X., & Suh, J. (2014) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1287 · Cited by 59
Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Imaging
Hu, H., Hema, M., Gu, Y., Zhang, Y., Yu, X., & Steinmetz, N. F. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b03956 · Cited by 59
Wen, A. M., Lee, K. L., Cao, P., Pangilinan, K. D., Carpenter, B. L., Lam, P. M. W., Veliz, F. A., Ghiladi, R. A., Advíncula, R. C., & Steinmetz, N. F. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00075 · Cited by 58
Finbloom, J. A., Han, K., Aanei, I. L., Hartman, E. C., Finley, D. T., Dedeo, M. T., Fishman, M., Downing, K. H., & Francis, M. B. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00424 · Cited by 58
Cruz, L., Romero, J. A. A., Iglesia, R. P., & Lopes, M. H. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00094 · Cited by 58
RGD cadherins and α2β1 integrin in cancer metastasis: A dangerous liaison
Casal, J. I., & Bartolomé, R. A. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.005 · Cited by 57
Yang, H. Y., Jang, M.-S., Li, Y., Fu, Y., Wu, T. P., Lee, J. H., & Lee, D. S. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.019 · Cited by 56
Visualization of exosomes from mesenchymal stem cells in vivo by magnetic resonance imaging
Liu, T., Zhu, Y., Zhao, R., Wei, X., & Xin, X. (2020) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2020.02.001 · Cited by 55
Dashti, N. H., Abidin, R. S., & Sainsbury, F. (2018) · ACS Nano · doi:10.1021/acsnano.8b01059 · Cited by 54
Lee, K. L., Carpenter, B. L., Wen, A. M., Ghiladi, R. A., & Steinmetz, N. F. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00061 · Cited by 53
Dual Functionalized Bacteriophage Qβ as a Photocaged Drug Carrier
Chen, Z., Li, N., Chen, L., Lee, J., & Gassensmith, J. J. (2016) · Small · doi:10.1002/smll.201601053 · Cited by 53
Self-citationDelivery of mitoxantrone using a plant virus-based nanoparticle for the treatment of glioblastomas
Lam, P., Lin, R. D., & Steinmetz, N. F. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01191e · Cited by 53
Herbert, F. C., Brohlin, O. R., Galbraith, T., Benjamin, C., Reyes, C. A., Luzuriaga, M. A., Shahrivarkevishahi, A., & Gassensmith, J. J. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00190 · Cited by 53
Natural Killer Cells for Therapy of Leukemia
Suck, G., Linn, Y. C., & Tonn, T. (2016) · Transfusion Medicine and Hemotherapy · doi:10.1159/000445325 · Cited by 51
The biomedical and bioengineering potential of protein nanocompartments
Demchuk, A. M., & Patel, T. R. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107547 · Cited by 48
Ju, C., Wen, Y., Zhang, L., Wang, Q., Xue, L., Shen, J., & Zhang, C. (2019) · Small · doi:10.1002/smll.201905688 · Cited by 47
Hu, H., Yang, Q., Baroni, S., Yang, H., Aime, S., & Steinmetz, N. F. (2019) · Nanoscale · doi:10.1039/c9nr02065a · Cited by 47
Glyco-decorated tobacco mosaic virus as a vector for cisplatin delivery
Liu, X., Liu, B., Gao, S., Wang, Z., Tian, Y., Wu, M., Jiang, S., & Niu, Z. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00100b · Cited by 46
Żochowska, M., Piguet, A.-C., Jemielity, J., Kowalska, J., Szołajska, E., Dufour, J., & Chroboczek, J. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.07.009 · Cited by 44
Switching the Targeting Pathways of a Therapeutic Antibody by Nanodesign
Bhattacharyya, S., Singh, R. D., Pagano, R. E., Robertson, J. D., Bhattacharya, R., & Mukherjee, P. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201105432 · Cited by 44
Pang, H., Huang, C.-Y., Chou, Y.-W., Lin, C.-J., Zhou, Z.-L., Shiue, Y., Wei, K., & Yang, H. (2019) · Nanoscale · doi:10.1039/c9nr01247h · Cited by 44
Using a Novel MicroRNA Delivery System to Inhibit Osteoclastogenesis
Yao, Y., Jia, T., Pan, Y., Gou, H., Li, Y., Sun, Y., Zhang, R., Zhang, K., Lin, G., Xie, J., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16048337 · Cited by 43
Belsham, G. J., Kristensen, T., & Jackson, T. (2020) · Virus Research · doi:10.1016/j.virusres.2020.197909 · Cited by 42
Kozłowska, A. K., Kaur, K., Topchyan, P., & Jewett, A. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1822-9 · Cited by 39
Teng, Z., Sun, S., Chen, H., Huang, J., Du, P., Dong, H., Xu, X., Mu, S., Zhang, Z., & Guo, H. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.09.030 · Cited by 39
Wu, H., Xing, H., Wu, M., Shen, F., Chen, Y., & Yang, T. (2020) · Theranostics · doi:10.7150/thno.46124 · Cited by 37
Zhang, J., Zhou, K., & Wang, Q. (2016) · Small · doi:10.1002/smll.201503487 · Cited by 34
Jin, X., Ma, J., Liang, X., Tang, K., Liu, Y., Yin, X., Zhang, Y., Zhang, H., Xu, P., Chen, D., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.036 · Cited by 34
Efficient mRNA delivery system utilizing chimeric VSVG-L7Ae virus-like particles
Zhitnyuk, Y., Gee, P., Lung, M. S. Y., Sasakawa, N., Xu, H., Saito, H., & Hotta, A. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.113 · Cited by 33
Targeted Delivery of a Photosensitizer to Aggregatibacter actinomycetemcomitans Biofilm
Suci, P. A., Kang, S., Gmür, R., Douglas, T., & Young, M. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00059-10 · Cited by 32
Cheng, Y., Lett, K. M., & Schaffer, C. B. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.05.010 · Cited by 32
Li, M., Qin, M., Song, G., Deng, H., Wang, D., Wang, X., Dai, W., He, B., Zhang, H., & Zhang, Q. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2020.06.006 · Cited by 32
Chen, D., Wu, Y., Zhang, W., Jiang, S., & Chen, S.-Z. (2016) · Scientific Reports · doi:10.1038/srep26934 · Cited by 31
Human NRAGE disrupts E-cadherin/β-catenin regulated homotypic cell–cell adhesion
Xue, B., Wen, C., Shi, Y.-H., Zhao, D., & Li, C. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.069 · Cited by 30
Park, J., Gao, H., Wang, Y., Hu, H., Simon, D. I., & Steinmetz, N. F. (2019) · Journal of Materials Chemistry B · doi:10.1039/c8tb02276c · Cited by 29
Su, Y., Kuo, L.-W., Hsu, C., Chiang, C., Lin, Y.-J., Chang, S., & Hu, S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.018 · Cited by 29
Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo
Suffian, I. F. M., Wang, J. T.-W., Hodgins, N. O., Klippstein, R., Garcia‐Maya, M., Brown, P. R., Nishimura, Y., Heidari, H., Bals, S., Sosabowski, J. K., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.012 · Cited by 28
Qazi, S., Uchida, M., Usselman, R. J., Shearer, R. D., Edwards, E., & Douglas, T. (2013) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-013-1075-4 · Cited by 26
A novel BK virus-based episomal vector for expression of foreign genes in mammalian cells
Benedetti, A. D., & Rhoads, R. E. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.8.1925 · Cited by 26
Yan, D., Teng, Z., Sun, S., Jiang, S., Dong, H., Gao, Y., Wei, Y., Qin, W., Liu, X., Yin, H., et al. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.12.007 · Cited by 26
Namdee, K., Khongkow, M., Boonrungsiman, S., Nittayasut, N., Asavarut, P., Temisak, S., Saengkrit, N., Puttipipatkhachorn, S., Hajitou, A., Ruxrungtham, K., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.04.012 · Cited by 26
Gao, S., Liu, X., Wang, Z., Jiang, S., Wu, M., Tian, Y., & Niu, Z. (2018) · Nanoscale · doi:10.1039/c8nr03748e · Cited by 25
Agrawal, A., & Manchester, M. (2012) · Biomacromolecules · doi:10.1021/bm3010885 · Cited by 24
Lung Tissue Delivery of Virus-Like Particles Mediated by Macrolide Antibiotics
Crooke, S. N., Schimer, J., Raji, I. O., Wu, B., Oyelere, A. K., & Finn, M. G. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00180 · Cited by 24
Pham, M. D., Epperla, C. P., Hsieh, C., Chang, W., & Chang, H. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00627 · Cited by 23
Bacteriophage MS2 As a Tool for Targeted Delivery in Solid Tumor Chemotherapy
Kolesanova, E. F., Melnikova, M. V., Bolshakova, T. N., Rybalkina, E. Y., & Ig, S. (2019) · Acta Naturae · doi:10.32607/20758251-2019-11-2-98-101 · Cited by 20
Nowicki, T. S., Farrell, C. P., Morselli, M., Rubbi, L., Campbell, K. M., Macabali, M. H., Berent-Maoz, B., Comín-Anduix, B., Pellegrini, M. A., & Ribas, A. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0300 · Cited by 20
Stimuli Responsive Hierarchical Assembly of P22 Virus-like Particles
Aumiller, W. M., Uchida, M., Biner, D. W., Miettinen, H. M., Lee, B., & Douglas, T. (2018) · Chemistry of Materials · doi:10.1021/acs.chemmater.7b04964 · Cited by 19
Haney, M. J., Klyachko, N. L., Zhao, Y., Kabanov, A. V., & Batrakova, E. V. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.396 · Cited by 14
Virus-Based Devices: Prospects for Allopoiesis
Dragnea, B. G. (2017) · ACS Nano · doi:10.1021/acsnano.7b01761 · Cited by 12
250 AVXS-101 phase 3 study in spinal muscular atrophy type 1
Day, J., Chiriboga, C. A., Crawford, T. O., Darras, B. T., Finkel, R. S., Connolly, A. M., Iannaccone, S. T., Kuntz, N. L., Peña, L. D. M., Schultz, M., et al. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-abn-2.202 · Cited by 4
Cited by
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Nanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
CRISPR/Cas9 therapeutics: progress and prospects
Li, T., Yang, Y., Qi, H., Cui, W., Zhang, L., Fu, X., He, X., Liu, M., Li, P.-F., & Yu, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01309-7 · Cited by 719
Nanoparticles in Drug Delivery: From History to Therapeutic Applications
Afzal, O., Altamimi, A. S. A., Nadeem, M. S., Alzarea, S. I., Almalki, W. H., Tariq, A., Mubeen, B., Murtaza, B. N., Iftikhar, S., Riaz, N., et al. (2022) · Nanomaterials · doi:10.3390/nano12244494 · Cited by 468
Metadata
- Authors
- Chen, L., Hong, W., Ren, W., Xu, T., Qian, Z., & He, Z.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2021-06-07
- Volume
- 6
- Issue
- 1
- Pages
- 225-225
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W3168395491
- Cited by
- 374
- References
- 304
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.